Overview


According to FutureWise analysis the market for hemostats in 2023 is US$ 2.98 billion, and is expected to reach US$ 4.86 billion by 2031 at a CAGR of 6.32%.

Hemostats refer to medical devices or substances used to control bleeding by promoting coagulation at the site of injury or during surgery. They are vital in surgical procedures where bleeding from blood vessels or tissue needs to be controlled to prevent complications and ensure successful surgical outcomes. Hemostats work by forming a mechanical barrier that seals the injured blood vessels or tissue. They promote coagulation by either facilitating platelet aggregation or activating clotting factors. Hemostatic agents can be classified based on their mechanism of action, such as mechanical hemostats, active hemostats, and flowable hemostats.

Mechanical hemostats are non-active agents that work by exerting pressure to compress the blood vessel or tissue to prevent blood flow. They include devices like clamps, sutures, and clips. Active hemostats, on the other hand, are substances that promote coagulation by facilitating the formation of a fibrin clot. These substances can either be derived from biological sources like human or animal plasma or can be synthetic materials. Flowable hemostats, such as sealants, work by adhering to the tissue and promoting coagulation by forming a mechanical barrier. Hemostats come in various forms, including gauze, sponge, film, powder, and sealant. These materials are designed to be biocompatible, absorbable, and appropriate for use in the human body. Some hemostats can be absorbed by the body once the bleeding has stopped, while others require removal once the surgical site has healed. Hemostats are widely used in various surgical procedures, including cardiovascular, orthopedic, and gastrointestinal surgeries. They are also used in emergency medicine, trauma care, and dentistry.

Recent developments by key players in Hemostats Market:

In July 2021, To broaden its portfolio of advanced surgical approaches, Baxter purchased the PerClot Polysaccharide Hemostatic System.

The hemostats market worldwide has witnessed substantial growth in recent times and is anticipated to maintain a steady growth rate in the future. One of the major drivers of the hemostats market is the rising number of surgical procedures being performed globally. As the population ages, the demand for surgical procedures is expected to increase, driving the demand for hemostats. Additionally, the growing trend towards minimally invasive surgeries is also influencing the growth of the hemostats market, as hemostats play a critical role in ensuring safety during these procedures. Another factor driving the growth of the hemostats market is advancements in hemostatic technologies. The development of new hemostatic agents and products, such as topical hemostats and sealants, has expanded the range of applications for hemostats and is driving the demand for these products. Additionally, the use of nanotechnology and other innovative technologies is expected to further drive growth in the hemostats market. The hemostats market is also benefiting from increasing healthcare expenditure globally. Governments and private firms around the world are investing heavily in healthcare infrastructure, including the purchase of medical devices such as hemostats.

One major challenge faced by the hemostats market is the high cost of some hemostatic agents and products. This can make it challenging for healthcare professionals to afford the latest technologies and can limit the growth of the market. Additionally, the use of some hemostatic agents has been associated with adverse events, which can lead to increased regulatory scrutiny and potentially limit this market’s growth.

FutureWise Market Research has published a report that provides an insightful analysis of Hemostats Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Hemostats Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • CR Bard Inc.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Integra LifeSciences
  • Marine Polymer Technologies, Inc.
  • Teleflex
  • Ethicon, Inc.
  • Pfizer, Inc.
  • Z-Medica LLC
  • Gelita Medical GmbH

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Thrombin-based hemostats
  • Oxidized regenerated cellulose-based hemostats
  • Combination hemostats 
  • Gelatin-based hemostats
  • Collagen-based hemostats

By Application

  • Orthopedic Surgery 
  • General Surgery
  • Neurological surgery
  • Cardiovascular surgery
  • Reconstructive surgery
  • Gynecological surgery
  • Other surgeries

By Formulation

  • Matrix & gel hemostats
  • Sheet & pad hemostats
  • Sponge hemostats
  • Powder hemostats

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Additionally, North America registered the highest share in the global market in 2022. North America, particularly the United States, holds a significant position in the global hemostats market, with a major contribution to its growth. The factors behind the hemostats market growth in North America include rising demand for minimally invasive surgeries, an increasing number of surgical procedures, and a rise in chronic diseases that require surgical intervention. Favorable healthcare infrastructure, reimbursement policies, and increased healthcare spending further fuel the growth of the hemostats market in the region. While the presence of significant market players fosters a highly competitive and innovative market environment, it is worth noting that other regions, including Europe and Asia-Pacific, are also expected to experience substantial growth in the hemostats market.

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key market trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Hemostats Market By Product, By Application, By Formulation and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Hemostats Market Variables, Trends and Scope
    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Hemostats Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Hemostats Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Hemostats Market, By Product Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)
    •   1. Thrombin-based hemostats
        2. Oxidized regenerated cellulose-based hemostats
        3. Combination hemostats
        4. Gelatin-based hemostats
        5. Collagen-based hemostats

  • 8.   Hemostats Market, By Application Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)
    •   1. Orthopedic Surgery
        2. General Surgery
        3. Neurological surgery
        4. Cardiovascular surgery
        5. Reconstructive surgery
        6. Gynecological surgery
        7. Other surgeries

  • 9.   Hemostats Market, By Formulation Historical Analysis 2017-2022 and Forecast 2023-2031 (USD million)
    •   1. Matrix and gel hemostats
        2. Sheet and pad hemostats
        3. Sponge hemostats
        4. Powder hemostats

  • 10.   North America Hemostats Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Hemostats Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Hemostats Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Hemostats Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. CR Bard Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. B. Braun Melsungen AG
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Baxter International, Inc.
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Integra LifeSciences
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Marine Polymer Technologies, Inc
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Teleflex
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Ethicon, Inc.
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Pfizer, Inc.
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Z-Medica LLC
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Gelita Medical GmbH.
         10.1. Company Overview (HQ, Business Segments, Employee Strength)
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients